SLC5A2 and nonpapillary renal cell carcinoma: In addition, future studies involving the use of other ccRCC cell lines with VHL mutations are warranted not only to validate our results but to also elucidate the molecular mechanisms underlying SGLT2-mediated ccRCC progression.